Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtre
1.
J. appl. oral sci ; 26: e20170451, 2018. graf
Article Dans Anglais | LILACS, BBO | ID: biblio-893699

Résumé

Abstract Local administration of toll-like receptor 9 (TLR9), agonist cytidine-phosphate-guanosine oligodeoxynucleotide (CpG ODNs), and CD40 ligand (CD40L) can decrease ligature-induced periodontal inflammation and bone loss in wild type (WT) mouse. Objective: This study aimed to explore whether such effect is dependent on TLR9 signaling. Material and Methods: Purified spleen B cells isolated from WT C57BL/6J mice and TLR9 knockout (KO) mice were cultured for 48 hours under the following conditions: CD40L, CpG+CD40L, CpG at low, medium and high doses. We determined B cell numbers using a hemocytometer at 24 h and 48 h. Percentages of CD1dhiCD5+ B cells were detected by flow cytometry. Interleukin-10 (IL-10) mRNA expression and protein secretion were measured by quantitative real-time polymerase chain reaction (qRT-PCR) and by ELISA, respectively. The silk ligature was tied around the maxillary second molars for 14 days, during which the CpG+CD40L mixture or PBS was injected into palatal gingiva on days 3, 6, and 9. Results: For both WT and TLR9 KO mice, CpG significantly induced B cell proliferation, increased IL-10 mRNA expression and protein secretion of IL-10 but reduced CD1dhiCD5+ B cells population; local injection of CpG+CD40L mixture significantly decreased alveolar bone loss and the number of TRAP-positive cells adjacent to the alveolar bone surface, and significantly increased the gingival mRNA expression of IL-10 and decreased RANKL and IFN-γ mRNA expression. Conclusions: These results indicated that CpG plus CD40L decreased periodontal inflammation and alveolar bone loss in a TLR9-independent manner in ligature-induced experimental periodontitis.


Sujets)
Animaux , Oligodésoxyribonucléotides/pharmacologie , Parodontite/traitement médicamenteux , Résorption alvéolaire/traitement médicamenteux , Ligand de CD40/pharmacologie , Cytidine/pharmacologie , Récepteur-9 de type Toll-like/effets des médicaments et des substances chimiques , Nucléotides guanyliques/pharmacologie , Valeurs de référence , Facteurs temps , Test ELISA , Lymphocytes B/effets des médicaments et des substances chimiques , Cellules cultivées , Adjuvants immunologiques/pharmacologie , Reproductibilité des résultats , Interleukine-10/analyse , Modèles animaux de maladie humaine , Récepteur-9 de type Toll-like/analyse , Réaction de polymérisation en chaine en temps réel , Cytométrie en flux , Gencive/effets des médicaments et des substances chimiques , Gencive/anatomopathologie , Souris de lignée C57BL
2.
Experimental & Molecular Medicine ; : 30-35, 1999.
Article Dans Anglais | WPRIM | ID: wpr-56321

Résumé

C-Terminal carboxyl methylation of a human placental 23 kDa protein catalyzed by membrane-associated methyltransferase has been investigated. The 23 kDa protein substrate methylated was partially purified by DEAE-Sephacel, hydroxyapatite and Sephadex G-100 gel filtration chromatographies. The substrate protein was eluted on Sephadex G-100 gel filtration chromatography as a protein of about 29 kDa. In the absence of Mg2+, the methylation was stimulated by guanine nucleotides (GTP, GDP and GTPgammaS), but in the presence of Mg2+, only GTPgammaS stimulated the methylation which was similar to the effect on the G25K/rhoGDI complex. AFC, an inhibitor of C-terminal carboxyl methylation, inhibited the methylation of human placental 23 kDa protein. These results suggests that the substrate is a small G protein different from the G25K and is methylated on C-terminal isoprenylated cysteine residue. This was also confirmed by vapor phase analysis. The methylated substrate protein was redistributed to membrane after in vitro methylation, suggesting that the methylation of this protein is important for the redistribution of the 23 kDa small G protein for its putative role in intracellular signaling.


Sujets)
Femelle , Humains , Grossesse , Cystéine/métabolisme , Protéines G/métabolisme , Nucléotides guanyliques/pharmacologie , Méthylation , Placenta/métabolisme , Placenta/enzymologie , Protéines de la grossesse/métabolisme , Protein Methyltransferases/métabolisme
SÉLECTION CITATIONS
Détails de la recherche